Med Learning Group

Curated by Signal

Online platform offering information for diabetes management

Overview

DB-relief is an online platform offering information on glucagon-like peptide-1 (GLP-1) receptor agonists in managing type 2 diabetes. The platform collects clinical trial data to provide treatment guidelines, resources, personalize therapy, patient-specific factors, tips on managing adverse events, and toolkits for diabetes management.

Key facts

Founded: 2019
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Cronix Technologies
Provider of AI-based solution for wait-time management
Health TechnologyNew York City, United States
Emerson Ecologics
Online supplier of medicines, supplements, and healthcare products
Health TechnologyManchester, United States
G LNK
AI based platform to simplifies collaboration in the healthcare industry
Health TechnologyNew York City, United States

About Med Learning Group

What does Med Learning Group do?

DB-relief is an online platform offering information on glucagon-like peptide-1 (GLP-1) receptor agonists in managing type 2 diabetes.

Where is Med Learning Group headquartered?

Med Learning Group is headquartered in New York City, United States.

When was Med Learning Group founded?

Med Learning Group was founded in 2019.

Which sector is Med Learning Group in?

Med Learning Group operates in Health Technology.

Who are Med Learning Group's competitors?

Companies similar to Med Learning Group include Cronix Technologies, Emerson Ecologics, and G LNK.